Evidence map›Paper›PMID 42436543›Full record

Observational studyBMC health services research2026

Dynamics of healthcare inequalities in type 2 diabetes mellitus across the COVID-19 pandemic: a real-world population-based study.

Isabel Aguilar-Palacio, M José Rabanaque, Adriana Gamba, Irantzu Bengoa-Urrengoechea, Irene López-Ferreruela, Sara Castel-Feced, Sara Malo

Abstract readObservational Study
In one paragraph

Observational study in BMC health services research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Isabel Aguilar-PalacioDepartment of Preventive Medicine and Public Health, University of Zaragoza, Zaragoza, Spain. iaguilar@unizar.es.ORCID http://orcid.org/0000-0001-7293-701X
M José RabanaqueDepartment of Preventive Medicine and Public Health, University of Zaragoza, Zaragoza, Spain.
Adriana GambaGrupo de Investigación en Servicios Sanitarios de Aragón (GRISSA), Fundación Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Spain.
Irantzu Bengoa-UrrengoecheaGrupo de Investigación en Servicios Sanitarios de Aragón (GRISSA), Fundación Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Spain.
Irene López-FerreruelaGrupo de Investigación en Servicios Sanitarios de Aragón (GRISSA), Fundación Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Spain.
Sara Castel-FecedDepartment of Preventive Medicine and Public Health, University of Zaragoza, Zaragoza, Spain.
Sara MaloDepartment of Preventive Medicine and Public Health, University of Zaragoza, Zaragoza, Spain.

Funding

Gobierno de Aragón B09-23RInstituto de Salud Carlos III PI22/01193
6 · The paper itself

Abstract

backgroundhealthcare inequalities have been widely documented, yet the COVID-19 pandemic may have altered their magnitude and direction. This study aimed to analyse the dynamics of healthcare inequalities in patients with type 2 diabetes mellitus (T2DM) before and after the pandemic using a real-world data approach.

methodswe conducted a real-world observational study including T2DM patients aged ≥ 45 from the CARhES cohort, a population-based dataset integrating clinical and administrative information from Aragón (Spain), between 2017 and 2022. Healthcare utilisation was assessed at two levels: Primary Care and specialist care. Socioeconomic, clinical, and healthcare variables were retrieved from electronic health records. We described healthcare utilisation patterns and trends across the study period and estimated adjusted prevalence ratios (PRs) for inequality axes (age, gender, migrant status, socioeconomic level, and rurality) using Poisson regression models at three time points (2017, 2020, 2022), adjusting for multimorbidity.

resultsA total of 86,407 T2DM patients were included. Almost all patients consulted a general practitioner (GP) each year and increased over time, while specialist consultations declined during the pandemic and had not recovered by 2022. Socioeconomic inequalities persisted or widened across most axes. After the pandemic, patients aged ≥ 80 were less likely to visit GP than younger patients, reversing pre-pandemic trends. Women continued to show higher GP use than men but fewer consulted with specialist, although the magnitude of the observed difference was small. Immigrants' access to specialists decreased relative to natives in 2022. active people with low socioeconomic status showed the lowest specialist consultations, while mutualists had the highest during the pandemic. Rural residents maintained greater reliance on Primary Care but fewer specialist visits post-pandemic. The explanatory power of socioeconomic variables declined in GP models, whereas multimorbidity gained influence during and after COVID-19.

conclusionsHealthcare inequalities among T2DM patients persisted and some patterns shifted after 2020. Although GP utilisation increased, nursing and specialist follow-up did not recover to pre-pandemic levels. These patterns underscore the need for targeted interventions to optimise care for older adults, women, migrants, rural residents, and low-income populations, with a focus on promoting digital inclusion and developing tailored healthcare pathways to advance health equity.

Indexed as

COVID-19Diabetes Mellitus, Type 2Healthcare DisparitiesPatient Acceptance of Health CareAccess to Primary CareAgedAged, 80 and overFemaleHumansMaleMiddle AgedPandemicsPrimary Health CareSocioeconomic Disparities in HealthSocioeconomic FactorsSpainCOVID-19Diabetes Mellitus, Type 2Healthcare disparitiesReal world data

Identifiers

PMID42436543
PMCPMC13640358

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.